Lamar Eaton

434 total citations
12 papers, 276 citations indexed

About

Lamar Eaton is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Lamar Eaton has authored 12 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Lamar Eaton's work include Estrogen and related hormone effects (6 papers), HER2/EGFR in Cancer Research (5 papers) and Advanced Breast Cancer Therapies (3 papers). Lamar Eaton is often cited by papers focused on Estrogen and related hormone effects (6 papers), HER2/EGFR in Cancer Research (5 papers) and Advanced Breast Cancer Therapies (3 papers). Lamar Eaton collaborates with scholars based in United States, Spain and Denmark. Lamar Eaton's co-authors include Bernard Fisher, Edwin R. Fisher, Norman Wolmark, Stewart Anderson, Elizabeth Tan-Chiu, Stanley G. Korenman, Dan Tulchinsky, José Baselga, Javier Cortés and M. Ferreira and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Lamar Eaton

12 papers receiving 266 citations

Peers

Lamar Eaton

ONCOL

PFM

SURGE

Qixia Han China

Saskia van de Ven Netherlands

H Robertshaw United Kingdom

Daniel Herr Germany

Sam Rotstein Sweden

M.J. Mitchell United Kingdom

Beth‐Ann Lesnikoski United States

In Ae Park South Korea

Harlinde De Schutter Belgium

Sabine Pöstlberger Austria

Qixia Han China

Lamar Eaton

208 ×1.2

85 ×0.7

ONCOL

162 ×1.7

PFM

31 ×0.6

59 ×1.3

SURGE

Citations per year, relative to Lamar Eaton Lamar Eaton (= 1×) peers Qixia Han

Countries citing papers authored by Lamar Eaton

Since Specialization

Citations

This map shows the geographic impact of Lamar Eaton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lamar Eaton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lamar Eaton more than expected).

Fields of papers citing papers by Lamar Eaton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lamar Eaton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lamar Eaton. The network helps show where Lamar Eaton may publish in the future.

Co-authorship network of co-authors of Lamar Eaton

This figure shows the co-authorship network connecting the top 25 collaborators of Lamar Eaton. A scholar is included among the top collaborators of Lamar Eaton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lamar Eaton. Lamar Eaton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Vergote, Ignace, Nicole Concin, Mansoor Raza Mirza, et al.. (2020). Phase Ib/II trial of tisotumab vedotin (TV) ± bevacizumab (BEV), pembrolizumab (PEM), or carboplatin (CBP) in recurrent or metastatic cervical cancer (innovaTV 205/ENGOT-cx8/GOG-3024).. Journal of Clinical Oncology. 38(15_suppl). TPS6095–TPS6095. 6 indexed citations

Vergote, I., Nicole Concin, Mansoor Raza Mirza, et al.. (2019). Phase I/II trial of tisotumab vedotin plus bevacizumab, pembrolizumab, or carboplatin in recurrent or metastatic cervical cancer (innovaTV 205/ENGOT-cx8). Annals of Oncology. 30. v433–v434. 2 indexed citations

Baselga, José, Serafín Morales, Ahmad Awada, et al.. (2017). A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer. Breast Cancer Research and Treatment. 163(3). 535–544. 16 indexed citations

Rugo, Hope S., Olivier Trédan, Jungsil Ro, et al.. (2017). A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer. Breast Cancer Research and Treatment. 165(3). 601–609. 21 indexed citations

Rugo, Hope S., Olivier Trédan, Jungsil Ro, et al.. (2015). Abstract PD5-1: Results from the phase 2 trial of ridaforolimus, dalotuzumab, and exemestane compared to ridaforolimus and exemestane in advanced breast cancer. Cancer Research. 75(9_Supplement). PD5–1. 8 indexed citations

Baselga, José, Serafín Morales, Ahmad Awada, et al.. (2013). Abstract P2-16-04: A phase 2 study of ridaforolimus (RIDA) and dalotuzumab (DALO) in estrogen receptor positive (ER+) breast cancer. Cancer Research. 73(24_Supplement). P2–16. 3 indexed citations

Blum, JL, Javier Cortés, HS Rugo, et al.. (2011). OT3-01-16: A Phase 2 Study of Ridaforolimus (RIDA) and Dalotuzumab (DALO) in Estrogen Receptor Positive (ER+) Breast Cancer.. Cancer Research. 71(24_Supplement). OT3–1. 1 indexed citations

Ebbinghaus, Scot, Joanne L. Blum, Javier Cortés, et al.. (2011). A phase II study of ridaforolimus (RIDA) and dalotuzumab (DALO) in estrogen receptor-positive (ER+) breast cancer.. Journal of Clinical Oncology. 29(15_suppl). TPS110–TPS110. 5 indexed citations

Eaton, Lamar. (2009). Mefloquine has more adverse effects than other drugs for malaria prophylaxis. BMJ. 339(oct13 2). b4167–b4167. 1 indexed citations

10.

Fisher, Edwin R., et al.. (2001). Fifteen‐year prognostic discriminants for invasive breast carcinoma. Cancer. 91(S8). 1679–1687. 18 indexed citations

11.

Fisher, Edwin R., Stewart Anderson, Elizabeth Tan-Chiu, et al.. (2001). Fifteen-year prognostic discriminants for invasive breast carcinoma. Cancer. 91(S8). 1679–1687. 164 indexed citations

12.

Korenman, Stanley G., Dan Tulchinsky, & Lamar Eaton. (1970). RADIO-LIGAND PROCEDURES FOR ESTROGEN ASSAY IN NORMAL AND PREGNANCY PLASMA. European Journal of Endocrinology. 65(1_Suppl). S291–S304. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact